Effect of low-dose oral contraceptives on lipoproteins and lipolytic enzymes: differences between two commonly used preparations.

@article{Leuven1984EffectOL,
  title={Effect of low-dose oral contraceptives on lipoproteins and lipolytic enzymes: differences between two commonly used preparations.},
  author={J. Leuven and L. Havekes and H. A. van der Kooij-Pontier and R. Starmans and H. Jansen and M. L. Bouwhuis-Hoogerwerf and H. A. de Pagter and L. W. Hessel},
  journal={Metabolism: clinical and experimental},
  year={1984},
  volume={33 11},
  pages={
          1039-42
        }
}
  • J. Leuven, L. Havekes, +5 authors L. W. Hessel
  • Published 1984
  • Medicine
  • Metabolism: clinical and experimental
    • Changes in circulating lipoproteins, which may be related to the risk for atherosclerotic vascular disease, were studied in a control group and in two groups of 24 or 26 women using different preparations of low-dose oral contraceptives for 3 months. One preparation contained 150 micrograms levo-norgestrel and 30 micrograms ethinylestradiol (Stediril-d 150/30); the other contained 750 micrograms lynestrenol and 37.5 micrograms ethinylestradiol (Ministat). No significant changes were found with… CONTINUE READING
    View on PubMed
    doi.org
    14 Citations
    Background Citations
    2
    14 Citations
    Citation Type

    Citation Type

    Effects of oral contraceptives on lipid metabolism.
    • 10
    Estrogenic effect of gestodene- or desogestrel-containing oral contraceptives on lipoprotein metabolism.
    • 33
    Effects of Different Oral Contraceptives on Apolipoprotein E
    • 2
    Changes in lipoprotein composition in women receiving two low-dose oral contraceptives containing ethinylestradiol and gonane progestins.
    • 29
    Effects of estrogen/progestin agents on plasma retinoids and chylomicron remnant metabolism.
    • 8
    Serum lipid and lipoprotein changes induced by preparations containing low‐dose ethinylestradiol plus levonorgestrel
    • 3
    Relationship between lipoprotein lipase activity and plasma sex steroid level in obese women.
    • 92
    • PDF
    Role of plasma lipoproteins in the pathogenesis of atherosclerotic disease, with special reference to sex hormone effects.
    • M. Tikkanen
    • Medicine
    • American journal of obstetrics and gynecology
    • 1990
    • 43
    Hormones in Lipoprotein Metabolism
    • 6
    Combined Oral Contraceptives: From Risk to Benefit?
    • 1

    References

    SHOWING 1-10 OF 23 REFERENCES
    Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. II. Serum lipoproteins and apolipoproteins.
    • 39
    Changes in serum high density lipoproteins in women on oral contraceptive drugs.
    • 39
    Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. I. Carbohydrate metabolism and liver function.
    • 27
    Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    • 337
    Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase.
    • 201
    • PDF
    Different effects of two progestins on plasma high density lipoprotein (HDL2) and postheparin plasma hepatic lipase activity.
    • 86
    Influence of contraceptive pill and menstrual cycle on serum lipids and high-density lipoprotein cholesterol concentrations.
    • 57
    • PDF
    On the metabolic function of heparin-releasable liver lipase.
    • 224
    Post-heparin plasma lipoprotein and hepatic lipases. Relationships to high density lipoprotein cholesterol and to apolipoprotein CII in familial hyperalphalipoproteinemic and in normal subjects.
    • 41
    Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase.
    • 303